Navigation Links
Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
Date:5/3/2012

SEATTLE, May 3, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has identified compounds that functionally interact with each of four additional orphan G protein-coupled receptors (GPCRs). Without compounds that functionally interact with orphan GPCRs, developing drugs targeting those receptors is extremely difficult. Omeros has now unlocked 37 of them, representing over 45 percent of the Class A orphan GPCRs. There are approximately 120 orphan GPCRs and Omeros expects to unlock a large percentage of them, focusing first on Class A orphan GPCRs.

The four additional orphan GPCRs unlocked by Omeros are GPR83, GPR150, GPR151 and GPR183. GPR83 has been implicated in memory, stress and control of emotions and is also associated with autoimmune and inflammatory diseases. GPR150 is linked to ovarian cancer, while GPR151 is involved with cognition. GPR183 is an important component of the immune system and plays a central role in controlling B-cell migration and T-cell-dependent antibody production. Omeros is in the process of filing broad patent applications around its unlocked orphan GPCRs and compound optimization efforts are in progress.

"Our GPCR program currently remains focused on rapidly unlocking orphan receptors and uniquely elucidating their respective signaling profiles, and our successes continue to mount," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "The data generated by this approach enable medicinal chemistry to develop potential therapeutics and feed directly into our primary patent objective – to exclusively control each receptor that we unlock together with the compounds that functionally interact with it."

Ongoing GPCR Program

Omeros is screening orphan GPCRs against its small-molecule chemical libraries using its proprietary, high-throughput cellular redist
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015 Research and Markets ( ... the "Wound Care -Traditonal, Advanced And ... And Forecasts" report to their offering. ... of the global Wound Care products market, ... offerings, competitive shares, financial performance, technology developments ...
(Date:7/27/2015)... 2015 According to the new ... (2014-2019) by Type (DNA ISH, RNA ISH), By Application ... (Hospitals, Pharma & Biotech Companies, Research Labs, CROs)", The ... 2014 and is estimated to reach $681.0 million by ... period, 2014 to 2019. Browse through the ...
(Date:7/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/v4wlnk/key_pharma_news ) has ... News Issue" newsletter to their offering. ... oncology pipeline and serves as a statement of ... 2015, with a large-scale potentially transformative acquisition by ... Pharma News covers all major developments in the ...
Breaking Medicine Technology:Global Wound Care Markets 2015-2020 - Traditonal, Advanced And Regenerative: Competitors And Opportunities 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 3Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3
... Colo., Oct. 14, 2011 Data presented at ... in Chicago, IL show that the pretreatment blood-based ... carcinoma (RCC) patients treated with a combination of ... by survival outcomes.   Patients who tested VeriStrat ...
... Pharmaceuticals, Inc. announced Friday a significant expansion of its ... methyl, and to continue advancing its earlier-stage pipeline. ... Paul Audhya, MD, as Vice President of ... Ph.D., as Vice President and Chief Regulatory and Compliance ...
Cached Medicine Technology:VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients 2VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients 3Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 2Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 3
(Date:7/28/2015)... ... July 28, 2015 , ... North American Seminars will ... fall of 2015 . These seventeen courses are pre-approved for CME credit ... Functional Mobility in the Older Adult , August 22, 2015 - August ...
(Date:7/28/2015)... ... ... the Veterans Fund of the United States, managing the United Veteran Beacon House (UVBH) for ... to help homeless Veterans by giving them “A hand up – not a hand out.” ... assists and supports Vets through the Veterans Fund of the United States (VFUS), ...
(Date:7/27/2015)... ... July 28, 2015 , ... Combination Product GMP Compliance:, Understanding FDA’s New ... http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug or device is hard ... can get messy in a hurry. In a 46-page draft guidance released in January, ...
(Date:7/27/2015)... , ... July 28, 2015 , ... The National ... inductee into the NAPW VIP Woman of the Year Circle. She is recognized with ... 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively for professional ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... wound center management. Earlier this year Wound Care Advantage beta launched ... for WCA wound centers. Customized learning paths allow for clinicians, physicians, hyperbaric ...
Breaking Medicine News(10 mins):Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3
... reimburses patients and physicians who have been shortchanged ... American Medical Association (AMA), along with the Medical Society ... State Medical Association, claims victory with the settlement agreement ... The $350 million settlement marks the largest monetary settlement ...
... Philadelphia Attorney Stephen Sheller,s Whistleblower Clients Help ... Criminal Fine in Eli Lilly & Company ... 2003 Representing Six Whistleblowers PHILADELPHIA, Jan. 15 ... ("Lilly") will pay federal and state governments ...
... Eli Lilly and Company announced today it has ... pay more than 1.4 billion in criminal and civil ... multiple whistleblower lawsuits that the pharmaceutical giant defrauded Medicare, ... with its market practices for its blockbuster atypical antipsychotic, ...
... transplanted because of the generosity of donors and their familiesPHILADELPHIA, ... kid on the football field, but he spent his life ... graduated high school. For a 16-year-old from Hazleton, Pa. ... certainly unique. But as his father Paul Sr. talked ...
... $515 Million Criminal Fine is Largest Individual Corporate Criminal ... 15 American pharmaceutical giant Eli Lilly and Company ... for promoting its drug Zyprexa for uses not approved ... of Justice announced today. This resolution includes ...
... CINCINNATI, Jan. 15, 2009 The Procter & Gamble,Company ... organizational changes: , -- Mariano ... June 30, 2009, after 33 years of service. He ... 2009, when he will focus on working,closely with his ...
Cached Medicine News:Health News:AMA Claims Victory With Record Breaking Settlement in Case Against Insurer 2Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 2Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 3Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 4Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 2Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 3Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 4Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 2Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 3Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 4Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 2Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 3Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 4Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 5Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 6Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 7Health News:Procter & Gamble Announces Organizational Changes 2
... provide you with everything you need ... evoked potential, or electro-oculogram. The ultra-bright ... to perform ERGs you never imagined ... negative response, and s-cone ERGs. Wireless ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... designed for high throughput microplate processing. The ... Stacker that handles up to 60 microplates ... model is equipped with a dual direct ... may be interfaced to increase flexibility as ...
... Processor is a precise, reliable and ... has been designed for OEM production. ... customised according to the method bottles ... able to process automatically the whole ...
Medicine Products: